Metabolic Heterogeneity in Patient Tumor-Derived Organoids by Primary Site and Drug Treatment
Joe T. Sharick(Vanderbilt University), Melissa C. Skala(University of Wisconsin–Madison), Mark C. Kelley(Vanderbilt University), Ingrid M. Meszoely(Fox Chase Cancer Center), Rebeca García‐Varela(University of Wisconsin–Madison), Susan Tsai(The Ohio State University Wexner Medical Center), Carley M. Sprackling(University of Wisconsin Carbone Cancer Center), Dustin A. Deming(University of Wisconsin–Madison), Mark E. Burkard(University of Wisconsin–Madison), Kristina A. Matkowskyj(University of Wisconsin–Madison), Christine M. Walsh(University of Calgary), Alka Choudhary(National Institute of Pharmaceutical Education and Research), Cheri A. Pasch(University of Wisconsin Carbone Cancer Center), Dan L. Pham(University of Wisconsin–Madison), Alexander A. Parikh(East Carolina University), Stephanie M. McGregor(University of Wisconsin–Madison), Karla Esbona(University of Wisconsin–Madison)
Cited by 144
Related Papers
Fluorescence lifetime imaging microscopy: fundamentals and advances in instrumentation, analysis, and applications
|Journal of Biomedical Optics|2020|835
Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers
|New England Journal of Medicine|2020|766